You have read all your free articles, to continue reading subscribe to read the rest of this content.
Lundbeck and Otsuka report new data from their trials evaluating brexpiprazole for the treatment of manic episodes associated with bipolar I disorder. Data from two global Phase III clinical trials evaluating the safety and efficacy of brexpiprazole for the treatment of patients with manic episodAlready a subscriber Login You have…
Vitamin B3 (nicotinamide) may prevent nerve cell damage leading to blindness in glaucoma, according to the world’s first clinical study in the field published in Clinical and Experimental Ophthalmology. The study was led by researchers at the Centre for Eye Research Australia in collaboration wAlready a subscriber Login You have…
Follicum has announced that data from studies on human Langerhans islets have shown positive effects on insulin release in line with the previously reported results on beta cells isolated from animals. The studies were performed through two different collaborations, one with Lund University and oAlready a subscriber Login You have…
Nykode Therapeutics has announced clinical results from the open label, dose escalation trial of its T cell focused pan-SARS-CoV-2 vaccine candidate (VB10.2210) in healthy individuals who were previously vaccinated with an approved mRNA vaccine. T cell responses were analyzed by ex vivo ELISpot uAlready a subscriber Login You have read…
